AKIN GUMP STRAUSS HAUER & FELD

Lobbying for UCB, INC. · Biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · Georgia · House · Senate · $80,000.00 income · posted Jul 21, 2025

Lobbying activity 1

Trade (domestic/foreign)

Issues related to global biopharmaceutical supply chains; Issues related to U.S. investment projects; Issues related to tariffs on pharmaceuticals.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.